| 
     At the 3rd Central Executive Committee Meeting on
    December 9, RENGO endorsed actions regarding revision of medical
    consulting fees for the peak period. These actions involve intensive
    movements such as a rally before the Ministry of Health and Welfare
    and on-the-street PR planned for the peak period of December
    15 and 17 when the Central Social Insurance Medical Council (CHUIKYO)
    will hold its general meeting.  
    Circumstances
    surrounding the Deliberations at CHUIKYO and the Steering Committee
    for the Council of Health Insurance and Welfare and RENGO's action 
    (1)The Central Social
    Insurance Medical Council (CHUIKYO) 
      
      
         | 
        
        (a) Circumstances surrounding
        the Deliberations | 
       
     
      
         | 
        
         Medical consultant fees
        are revised once every two years and the coming fiscal year will
        mark the next fee revision. On November 26, the Japan Medical
        Association, the Japan Dental Association, and the Japan Pharmaceutical
        Association, each submitted demands for revising their consulting
        fees to the Central Social Insurance Medical Council (CHUIKYO). 
        Their demands follow: 
        
          Increase Social Insurance
          medical consulting fees 3.6% 
          2.6% for fluctuations in prices and labor costs and 1.0% for
          technical innovations in medical treatment and advances in medicine
          and medical care.
          Increase dental consulting
          fees 3.9% and 7.5% 
          2.8% for fluctuation in prices and labor costs and 1.1% for technological
          advances in dental care. 
          7.5% for funds to raise charge points for patients' first and
          return dental visits to levels equal to that of medical doctors.
          Increase pharmaceutical
          fees 1.5% 
          1.5% for increases such as labor costs. 
          Moreover, on December 1 at CHUIKYO, the Japan Pharmaceutical
          Association requested an average increase of 4.5% in consulting
          fees (to be shifted to technical fees) to recoup their losses
          from adjusting differentials in drug prices.
        
        
          Medical
          institutions demand that health organizations pay medical consulting
          fees for the portion covered by their patients' insurance. Medical
          institutions have replaced consulting procedures with a point
          system. Reimbursements for medical fees are paid in accordance
          with those points. Afterward treatment, health organizations
          bill the patient's insurance company. This is a rough sketch
          of how Japanese insurance medical care works. 
          Drug prices are set under the existing drug tariff system to
          which the health organizations refer when they reimburse medical
          institutions. However, the actual market prices that medical
          institutions pay for drugs from pharmaceutical companies are
          different. This results in marginal profits that create substantial
          revenue for medical institutions. Since drug costs occupy the
          lions share of health insurance expenditures in Japan, this has
          been a critical problem in the movement to solve differentials.  
 | 
       
      
    
      
         | 
        
         At the Central Social Insurance
        Medical Council (CHUIKYO) on December 1, the insurers including
        RENGO, the National Federation of Health Insurance Societies
        (KENPOREN), and Japanese Federation of Employers' Associations
        (NIKKEIREN) confronted the medical institution side, the Japan
        Medical Association and others, regarding their submitted demand
        to revise medical fees. 
        According to the "survey on the state of the medical economy"
        published that day, the average medical practitioner's income
        is ¥2,355,000, an increase of ¥360,000 over levels in
        the same survey conducted in September 1997. In addition, revenues
        at general hospitals, excluding national/public hospitals, increased.
 
        Struggling with lost insurance premium revenues from wage decreases
        due to the flat economy on the one hand and rising medical costs,
        especially in contributions for health care for the elderly,
        on the other, the insurers emphasized the absurdity of the demand-even
        a 3.6% increase would total more than ¥1 trillion. 
        Contribution
        costs for health care for the elderly that should be paid to
        health organizations are allocated to each individual insurance
        system according to the number of subscribers. 
        As no accord was reached
        on consulting fee revision the last time, both claims were submitted
        on that report at midnight December 19, 1997. Eventually, the
        decision to raise fees was decided politically. Whether or not
        the report can be compiled is the big issue in not letting them
        make it a political decision this time. 
        The peak of a decisive battle between the medical side and the
        insurance side will be December 15 and 17, when CHUIKYO meets,
        before the Ministry of Finance is scheduled to announce the preliminary
        budget.  | 
       
     
    (2)The Council on Health
    Insurance and Welfare/Steering Committee 
      
         | 
        
        (a) Circumstances surrounding
        the Deliberation | 
       
     
      
         | 
        
        On July 29 this year, the
        Japan Medical Association and the LDP agreed to discontinue patient
        co-payments as part of drug charges. Patient co-payments for
        part of the drug fees were introduced in September 1997 in order
        to restrain drug costs which commanded a relatively high percentage
        of national health expenditures compared to the that of other
        countries. The Japan Medical Association has requested that the
        LDP to abolish it because it keeps patients from seeking medical
        consultations, resulting in a decline in revenues for medical
        institutions. The council enacted a temporary special measure
        without revising the law so that from July 1999 drug fees for
        the elderly were partially subsidized by national expenditures.
        Now there are plans to abolish the system introduced on September
        1997 this coming April. Medical expenditures are anticipated
        to rise to ¥490 billion due to that measure and in order
        to cover the deficit, measures to increase individual burdens
        were submitted to the Steering Committee of the Council on November
        15 and December 1 as items of discussion. | 
       
     
      
         | 
        
        On the paying side, RENGO,
        KENPOREN, NIKKEIREN and the National Insurance Society (KOKUHO)
        strongly opposed the Ministry of Health and Welfare's failure
        to introduce any radical reform while increasing patient burden
        as an item of discussion to the steering committee. In particular,
        we strongly protested that *the increased burden enacted in September
        1997 was introduced on the presupposition that radical reform
        in 2000 fiscal year would be implemented. And that *the government's
        public promise, namely that by all means they would conduct radical
        reform of welfare system for the elderly and enforce a nursing-care
        insurance system, is now being thrown in the wastebasket. 
        On November 15 and December 1 the steering committee did not
        enter into any concrete discussions. And with the impending year-end
        budget compilation, the scheduled committee on December 13 will
        be the decisive day. | 
       
      |